Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research

Addiction

Volumn 111, Issue 12, 2016, Pages 2230-2247

  Beard, Emma ^a   Dienes, Zoltan ^b   Muirhead, Colin ^c   West, Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Addiction; Bayes factors; Bayesian; hypothesis testing; non significant; RCT

Indexed keywords

ADDICTION MEDICINE; BAYES THEOREM; HUMAN; MATHEMATICS; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

ADDICTION MEDICINE; BAYES THEOREM; BIOMEDICAL RESEARCH; HUMANS; MATHEMATICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84994274975     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13501     Document Type: Article

References (53)

1. West R. Using Bayesian analysis for hypothesis testing in addiction science. Addiction 2016; 111: 3–4.
2. Jeffreys H. Theory of Probability. Oxford: Clarendon Press; 1961.
3. Wagenmakers E.-J. A practical solution to the pervasive problems of p values. Psychon Bull Rev 2007; 14: 779–4.
4. Rouder J. N., Speckman P. L., Sun D., Morey R. D., Iverson G. Bayesian t-tests for accepting and rejecting the null hypothesis. Psychon Bull Rev 2009; 16: 225–37.
5. Gallistel C. The importance of proving the null. Psychol Rev 2009; 116: 439.
6. Schervish M. J. P values: what they are and what they are not. Am Statistician 1996; 50: 203–6.
7. Berger J. O. Statistical Decision Theory and Bayesian Analysis. Berlin: Springer Science and Business Media; 2013.
8. Dienes Z. Using Bayes to get the most out of non-significant results. Front Psychol 2014; 5: 781.
9. Bayes C. J. Factor Calculator. R code 2011. Available at: http://www.lifesci.sussex.ac.uk/home/Zoltan_Dienes/inference/bayesFactorCalc2.R (accessed 1 March 2016).
10. Baguley T., Kaye W. S. Review of understanding psychology as a science: an introduction to scientific and statistical inference. Br J Math Stat Psychol 2010; 63: 695–8.
11. Lee M., Wagenmakers E. Bayesian Modeling for Cognitive Science: A Practical Course. Cambridge: Cambridge University Press; 2013.
12. Rouder J. N., Morey R. D., Speckman P. L., Province J. M. Default Bayes factors for ANOVA designs. J Math Psychol 2012; 56: 356–74.
13. Baguley T. Serious Stats: A Guide to Advanced Statistics for the Behavioral Sciences. Basingstoke: Palgrave Macmillan; 2012.
14. Morey R., Rouder J., Jamil T. Bayes Factor: computation of Bayes factors for common designs. R package version 09. 2014; 8. Available from: https://cran.r-project.org/web/packages/BayesFactor/BayesFactor.pdf (accessed 1 March 2016).
15. Koch M., Riss P., Umek W., Hanzal E. The primary outcomes and power calculations in clinical RCTs in urogynecology—need for improvement? Trials 2015; 16: 1.
16. Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 2001; 322: 989–91.
17. Sprenger J. The Objectivity of Subjective Bayesian Inference 2015. Available at: http://philsci-archive.pitt.edu/11936/1/ObjectiveBayesianStatistics_v3.pdf (accessed 1 March 2016).
18. Rouder J. N. Optional stopping: no problem for Bayesians. Psychon Bull Rev 2014; 21: 301–8.
19. Kypri K., McCambridge J., Vater T., Bowe S. J., Saunders J. B., Cunningham J. A. et al. Web-based alcohol intervention for Māori university students: double-blind, multi-site randomized controlled trial. Addiction 2013; 108: 331–8.
20. Li L., Wu Z., Liang L. J., Lin C., Zhang L., Guo S. et al. An intervention targeting service providers and clients for methadone maintenance treatment in China: a cluster-randomized trial. Addiction 2013; 108: 356–66.
21. Ward K. D., Asfar T., Ali A. R., Rastam S., Weg M. W. V., Eissenberg T. et al. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction 2013; 108: 394–3.
22. Borland R., Balmford J., Benda P. Population-level effects of automated smoking cessation help programs: a randomized controlled trial. Addiction 2013; 108: 618–28.
23. Rendall-Mkosi K., Morojele N., London L., Moodley S., Singh C., Girdler-Brown B. A randomized controlled trial of motivational interviewing to prevent risk for an alcohol-exposed pregnancy in the Western Cape, South Africa. Addiction 2013; 108: 725–32.
24. Coffin P. O., Santos G. M., Das M., Santos D. M., Huffaker S., Matheson T. et al. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction 2013; 108: 751–61.
25. Gilbert H. M., Leurent B., Sutton S., Alexis-Garsee C., Morris R. W., Nazareth I. ESCAPE: a randomised controlled trial of computer-tailored smoking cessation advice in primary care. Addiction 2013; 108: 811–9.
26. Alessi S. M., Petry N. M. A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. Addiction 2013; 108: 900–9.
27. Richmond R., Indig D., Butler T., Wilhelm K., Archer V., Wodak A. A randomized controlled trial of a smoking cessation intervention conducted among prisoners. Addiction 2013; 108: 966–74.
28. Levin F. R., Mariani J., Brooks D. J., Pavlicova M., Nunes E. V., Agosti V. et al. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction 2013; 108: 1084–94.
29. Okuyemi K. S., Goldade K., Whembolua G. L., Thomas J. L., Eischen S., Sewali B. et al. Motivational interviewing to enhance nicotine patch treatment for smoking cessation among homeless smokers: a randomized controlled trial. Addiction 2013; 108: 1136–44.
30. Gustafson D. H., Quanbeck A. R., Robinson J. M., Ford J. H., Pulvermacher A., French M. T. et al. Which elements of improvement collaboratives are most effective? A cluster-randomized trial. Addiction 2013; 108: 1145–57.
31. Kypri K., Hallett J., Howat P., McManus A., Maycock B., Bowe S. et al. Randomized controlled trial of proactive web-based alcohol screening and brief intervention for university students. Arch Intern Med 2009; 169: 1508–14.
32. Andrews S., Sorensen J. L., Guydish J., Delucchi K., Greenberg B. Knowledge and attitudes about methadone maintenance among staff working in a therapeutic community. J Mainten Addict 2005; 3: 47–59.
33. Livingston J. D., Milne T., Fang M. L., Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction 2012; 107: 39–50.
34. Hser Y.-I. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis 2007; 26: 51–60.
35. Mattick R. P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3.
36. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; 1: CD000146.
37. Floyd R. L., Sobell M., Velasquez M. M., Ingersoll K., Nettleman M., Sobell L. et al. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med 2007; 32: 1–10.
38. Ingersoll K. S., Ceperich S. D., Nettleman M. D., Karanda K., Brocksen S., Johnson B. A. Reducing alcohol-exposed pregnancy risk in college women: initial outcomes of a clinical trial of a motivational intervention. J Subst Abuse Treat 2005; 29: 173–80.
39. Tiihonen J., Kuoppasalmi K., Föhr J., Tuomola P., Kuikanmäki O., Vorma H. et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry 2007; 164: 160–2.
40. Colfax G. N., Santos G.-M., Das M., Santos D. M., Matheson T., Gasper J. et al. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry 2011; 68: 1168–75.
41. Meini M., Moncini M., Cecconi D., Cellesi V., Biasci L., Simoni G. et al. Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. Curr Pharm Des 2011; 17: 1376–83.
42. Lancaster T., Stead L. F. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2005; 3: CD001007.
43. Petry N. M., Martin B., Cooney J. L., Kranzler H. R. Give them prizes and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000; 68: 250.
44. Barnett N. P., Tidey J., Murphy J. G., Swift R., Colby S. M. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug Alcohol Depend 2011; 118: 391–9.
45. Litt M. D., Kadden R. M., Kabela-Cormier E., Petry N. M. Changing network support for drinking: network support project 2-year follow-up. J Consult Clin Psychol 2009; 77: 229.
46. Hughes J. R., Stead L. F., Hartmann-Boyce J., Cahill K., Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014; 1: CD000031.
47. Findling R. L., Pagano M. E., McNamara N. K., Stansbrey R. J., Faber J. E., Lingler J. et al. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. Child Adolesc Psychiatr Ment Health 2009; 3: 11.
48. Keller M. B., Trivedi M. H., Thase M. E., Shelton R. C., Kornstein S. G., Nemeroff C. B. et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry 2007; 68: 1246–56.
49. Bonnet U., Specka M., Stratmann U., Ochwadt R., Scherbaum N. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: Cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and-metabolites in serum. Drug Alcohol Depend 2014; 143: 189–97.
50. Smeerdijk M., Keet R., Dekker N., van Raaij B., Krikke M., Koeter M. et al. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. Psychol Med 2012; 42: 1626–36.
51. Hettema J. E., Hendricks P. S. Motivational interviewing for smoking cessation: a meta-analytic review. J Consult Clin Psychol 2010; 78: 868.
52. Alterman A. I., Gariti P., Cook T. G., Cnaan A. Nicodermal patch adherence and its correlates. Drug Alcohol Depend 1999; 53: 159–65.
53. Hollands G. J., McDermott M. S., Lindson-Hawley N., Vogt F., Farley A., Aveyard P. Interventions to increase adherence to medications for tobacco dependence. Cochrane Database Syst Rev 2015; 2: CD009164.